We received the "O-Nexus Award" at U-START UP KANSAI 2026, and the "Challenging Spirit Category Audience Award and Special Award" at the EY Entrepreneur of the Year 2026 Japan Kansai Region.
RadioNano Therapeutics Inc. (Headquarters: Kyoto City, Kyoto Prefecture; Representative Director: Masatoshi Chiba; hereinafter referred to as "the Company") has received the "O-Nexus Award" at the open pitch of "U-START UP KANSAI 2026," a program supporting the business development of university-based startups. This program is organized by the Osaka Chamber of Commerce and Industry and the Kansai Innovation Initiative (KSII).
Furthermore, we are pleased to announce that our President and CEO, Masatoshi Chiba, received the Audience Award and a Special Award in the Challenging Spirit category at the "EY Entrepreneur of the Year 2026 Japan" Kansai regional awards program, hosted by EY Japan.
■ U-START UP KANSAI 2026 Open Pitch "O-Nexus Award"
On Thursday, October 8, 2026, the open pitch (final judging round) of "U-START UP KANSAI 2026" was held at JAM BASE (Grand Green Osaka, Kita-ku, Osaka), and our company also took the stage. This year, we received a record-breaking 75 entries from both domestic and international participants, and 10 finalists who passed the document screening gave their pitches.
Our company presented on the topic of "Development of Novel Boron-Containing Nanoparticle Formulations for Boron Neutron Capture Therapy (BNCT) in Cancer Radiation Therapy" and received the "O-Nexus Award." The prize is a one-year membership to the O-Nexus coworking space. O-Nexus is a life science-focused innovation campus located within "Nakanoshima Qross," an international hub for future medical care in Nakanoshima, Osaka.
Event Name: University-Originated Startup Business Development Support Program "U-START UP KANSAI 2026" Open Pitch
Date: Thursday, October 8, 2026
Venue: JAM BASE Conference (Kita-ku, Osaka)
Organizers: Osaka Chamber of Commerce and Industry, Kansai Innovation Initiative (KSII)
Note: Held as a side event of Global Startup EXPO 2026.
■ EY Entrepreneur of the Year 2026 Japan Kansai Region: "Challenging Spirit Category Special Award, Audience Award"
The "EOY 2026 Japan Kansai Regional Competition" was held on Wednesday, October 14, 2026. Our President and CEO, Masatoshi Chiba, received the Audience Award and a Special Award in the Challenging Spirit category at this competition.
The EY Entrepreneur of the Year is an international awards program that celebrates the efforts and achievements of entrepreneurs who venture into new business areas, and is held in approximately 80 countries and regions worldwide. The judging is based on four criteria: entrepreneurial spirit, purpose, growth, and impact.
Award Program Name: EY Entrepreneur of the Year 2026 Japan (EOY 2026 Japan) Kansai Region
Date: Wednesday, October 14, 2026
Organized by: EY Japan
Awards: Special Award in the Challenging Spirit category, Audience Award
■ Comment from President and CEO Masatoshi Chiba
"We are deeply honored to receive two awards simultaneously. We would like to express our sincere gratitude to the judges, organizers, and everyone who showed support for our efforts at the venue. Our company is moving forward with the clinical development of RN-501, a boron-based drug for BNCT, based on technology originating from Kyoto University. Encouraged by these awards, we will deepen our collaboration with the Kansai life science ecosystem, including O-Nexus, and work together as a company to deliver a BNCT treatment originating in Japan to patients around the world."
■ About RadioNano Therapeutics Inc.
Our company is a drug discovery startup originating from Kyoto University, aiming to implement novel boron-based drugs for boron neutron capture therapy (BNCT), a promising next-generation cancer treatment. Our foundation lies in the "neutron capture therapy using highly hydrophilic boron-containing inorganic nanoparticles" technology developed by Professor Naoki Komatsu and Professor Minoru Suzuki of Kyoto University. We are driving the entire process from research and development to clinical development and commercialization of our lead pipeline, RN-501.
Company Name: RadioNano Therapeutics Co., Ltd.
Location: 36-1 Yoshida Honmachi, Sakyo-ku, Kyoto City, Kyoto Prefecture
Representative: Masatoshi Chiba, President and CEO
Established: April 1, 2024
URL: https://www.radionano-tx.com/
[Inquiries regarding this matter]
RadioNano Therapeutics Inc.
Executive Vice President (in charge of Administration Department)Hiroshi Kawai
E-mail: contact@radionano-tx.com